Results 261 to 270 of about 378,823 (394)
Development of a Conjugate Vaccine Targeting Human IgE for Long‐Term Prevention of Anaphylaxis
Allergy, EarlyView.
Vincent Serra, Laurent L. Reber
wiley +1 more source
This study reports the three‐dimensional structure of an important cat allergen, Fel d 4, that shares high homology with Equ c 1 (i.e., major horse allergen) and Can f 6 (i.e., dog allergen). The C‐terminal region of the Fel d 4 contains a major IgE‐reactive epitope.
Nikolina Todorović +14 more
wiley +1 more source
Correction: Microplastic exposure and allergic rhinitis: Network toxicology, and molecular docking insights. [PDF]
Wang Y, Xu D.
europepmc +1 more source
LAR patients who respond to AIT during the first year and are treated for two more years continue improving (less symptoms and medication intake) during the following seven years. AIT prevents the onset of asthma and allergic sensitizations in responder LAR individuals during the seven years following discontinuation.
Almudena Testera‐Montes +9 more
wiley +1 more source
Probiotic therapy as adjuvant for allergic rhinitis: an overview of systematic reviews and meta-analyses. [PDF]
Wang Z +7 more
europepmc +1 more source
ABSTRACT Allergies are one of the major health challenges of our time, associated with a high individual burden of disease and high costs for the healthcare system. Given their prevalence, allergies are also highly relevant from a public health perspective. The development of allergic diseases is multifactorial. In addition to individual factors (e.g.,
Jobst Augustin +13 more
wiley +1 more source
Identification of SIN3A as a Promising Epigenetic Target Against Allergic Rhinitis. [PDF]
Li H, Wang R, Yu B, Zeng J, Xiao Z.
europepmc +1 more source
Allergic rhinitis management: a survey on Italian primary care pediatricians [PDF]
Michele Miraglia del Giudice +5 more
openalex +1 more source

